ARTICLE | Company News
Elpidera, Moderna Therapeutics chemistry news
May 18, 2015 7:00 AM UTC
Moderna launched Elpidera to develop mRNA-based treatments for rare diseases. Greg Licholai, formerly SVP for real-world and late-stage research at Quintiles Transnational Holdings Inc. (NYSE:Q, Rese...